|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-8-31
|
|
pubmed:abstractText |
Efficacy of intravenous thrombolysis in acute ischemic stroke declines with increasing time to treatment initiation. Previous small-scale studies suggested that the earlier patients arrive, the longer it takes to administer recombinant tissue plasminogen activator.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2001-4
|
|
pubmed:meshHeading |
pubmed-meshheading:20689080-Aged,
pubmed-meshheading:20689080-Aged, 80 and over,
pubmed-meshheading:20689080-Austria,
pubmed-meshheading:20689080-Female,
pubmed-meshheading:20689080-Fibrinolytic Agents,
pubmed-meshheading:20689080-Humans,
pubmed-meshheading:20689080-Male,
pubmed-meshheading:20689080-Middle Aged,
pubmed-meshheading:20689080-Prospective Studies,
pubmed-meshheading:20689080-Recombinant Proteins,
pubmed-meshheading:20689080-Registries,
pubmed-meshheading:20689080-Stroke,
pubmed-meshheading:20689080-Thrombolytic Therapy,
pubmed-meshheading:20689080-Time Factors,
pubmed-meshheading:20689080-Tissue Plasminogen Activator,
pubmed-meshheading:20689080-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Stroke thrombolysis: having more time translates into delayed therapy: data from the Austrian Stroke Unit Registry.
|
|
pubmed:affiliation |
Department of Neurology, Hospital Barmherzige Brueder, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
